Patents/Assignees

ABLEVIA BIOTECH GmbH

2 patents in portfolio

US12011484utility2024
Compound for the Sequestration of Undesirable Antibodies in a Patient
0 cites
US11986536utility2024
Compound for the Sequestration of Undesirable Antibodies in a Patient
0 cites